Three of the original studies comprising the combined dataset included T2D patients (44–46), a total of 8 samples, and the percentage of p16-expressing beta cells was not significantly higher in these samples than in non-diabetic subjects, suggesting that larger patient sample numbers are required for this analysis (Supplementary Figure S1D). The gene discussed is CDKN2A; the disease is type 2 diabetes mellitus.